0000805928-22-000105.txt : 20220808
0000805928-22-000105.hdr.sgml : 20220808
20220808174951
ACCESSION NUMBER: 0000805928-22-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220804
FILED AS OF DATE: 20220808
DATE AS OF CHANGE: 20220808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freitag Gregory Gene
CENTRAL INDEX KEY: 0001492710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 221145724
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axogen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
STREET 2: SUITE 400
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: AxoGen, Inc.
DATE OF NAME CHANGE: 20111004
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
wf-form4_165999536701295.xml
FORM 4
X0306
4
2022-08-04
0
0000805928
Axogen, Inc.
AXGN
0001492710
Freitag Gregory Gene
13631 PROGRESS BLVD.
SUITE 400
ALACHUA
FL
32615
1
0
0
0
Common Stock
2022-08-04
4
S
0
24000
10.64
D
387515
D
Common Stock
2022-08-08
4
S
0
13046
10.37
D
374469
D
The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.35 to $10.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reported price in Colum 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging for $10.15 to $10.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote,
/s/Gregory Freitag
2022-08-08